Do valsartan and carvedilol contain any sulfur atoms in their chemical structures?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Chemical Structure Analysis: Sulfur Content in Valsartan and Carvedilol

Neither valsartan nor carvedilol contains sulfur atoms in their chemical structures.

Valsartan Structure

Valsartan is chemically described as N-(1-oxopentyl)-N-[[2′-(1H-tetrazol-5-yl)[1′-biphenyl]-4-yl]methyl]-L-valine, with the empirical formula C₂₄H₂₉N₅O₃ 1. This molecular formula contains only carbon, hydrogen, nitrogen, and oxygen—no sulfur (S) atoms are present.

The drug's structure consists of:

  • A tetrazole ring
  • Biphenyl groups
  • A valine derivative
  • An amide linkage

None of these structural components incorporate sulfur moieties 1, 2.

Carvedilol Structure

Carvedilol is (±)-1-(carbazol-4-yloxy)-3-[[2-(o-methoxyphenoxy)ethyl]amino]-2-propanol with the molecular formula C₂₄H₂₆N₂O₄ 3. This formula similarly contains only carbon, hydrogen, nitrogen, and oxygen—no sulfur atoms.

The structural features include:

  • A carbazole ring system
  • Methoxyphenoxy groups
  • A propanol backbone with secondary amine

Again, sulfur is completely absent from this molecular architecture 3.

Clinical Relevance

This distinction is particularly important for patients with documented sulfonamide allergies. Patients with sulfonamide antibiotic allergies can safely receive both valsartan and carvedilol, as there is no structural basis for cross-reactivity 4. The concern about "sulfur-containing" medications in sulfonamide-allergic patients specifically relates to the sulfonamide moiety (SO₂NH₂), which neither of these cardiovascular agents possesses.

Key Differentiation Points:

  • Sulfur-containing compounds (like sulfates, sulfites, or elemental sulfur) have no cross-reactivity with sulfonamide antibiotics 4
  • Sulfonamide antibiotics contain the aromatic amine group at the N4 position attached to the sulfonamide moiety
  • Valsartan and carvedilol contain neither sulfur atoms nor sulfonamide groups

Both medications are appropriate choices for heart failure management in patients with sulfonamide allergies, as evidenced by their widespread use in guideline-directed medical therapy for HFrEF without sulfur-related contraindications 5, 6, 7, 8, 9.

References

Research

Two isotypical disodium salts of the antihypertensive agent valsartan.

Acta crystallographica. Section C, Structural chemistry, 2026

Guideline

drug allergy: a 2022 practice parameter update.

Journal of Allergy and Clinical Immunology, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.